These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8946928)

  • 1. Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies.
    Shiohara M; Spirin K; Said JW; Gombart AF; Nakamaki T; Takeuchi S; Hatta Y; Morosetti R; Tasaka T; Seriu T; Bartram C; Miller CW; Tomonaga M; Koeffler HP
    Leukemia; 1996 Dec; 10(12):1897-900. PubMed ID: 8946928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
    Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S
    Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the INK4 family of genes in prostate carcinomas.
    Park DJ; Wilczynski SP; Pham EY; Miller CW; Koeffler HP
    J Urol; 1997 May; 157(5):1995-9. PubMed ID: 9112579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
    Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
    Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of a family of cyclin-dependent kinase inhibitor genes (p15/MTS2/INK4b and p18/INK4c) in non-small cell lung cancers.
    Kawamata N; Miller CW; Koeffler HP
    Mol Carcinog; 1995 Dec; 14(4):263-8. PubMed ID: 8519415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas.
    Kawamata N; Seriu T; Koeffler HP; Bartram CR
    Cancer; 1996 Feb; 77(3):570-5. PubMed ID: 8630967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M; Xiong Y
    Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the p15, p16,and p18 genes in osteosarcoma.
    Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP
    Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.
    Okuda T; Hirai H; Valentine VA; Shurtleff SA; Kidd VJ; Lahti JM; Sherr CJ; Downing JR
    Genomics; 1995 Oct; 29(3):623-30. PubMed ID: 8575754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood.
    Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J
    Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27/Kip1 mutation found in breast cancer.
    Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
    Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Backbone dynamics of the CDK inhibitor p19(INK4d) studied by 15N NMR relaxation experiments at two field strengths.
    Renner C; Baumgartner R; Noegel AA; Holak TA
    J Mol Biol; 1998; 283(1):221-9. PubMed ID: 9761685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood.
    Ohnishi H; Hanada R; Horibe K; Hongo T; Kawamura M; Naritaka S; Bessho F; Yanagisawa M; Nobori T; Yamamori S; Hayashi Y
    Leukemia; 1996 Jul; 10(7):1104-10. PubMed ID: 8683987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies.
    Ogawa S; Hangaishi A; Miyawaki S; Hirosawa S; Miura Y; Takeyama K; Kamada N; Ohtake S; Uike N; Shimazaki C
    Blood; 1995 Aug; 86(4):1548-56. PubMed ID: 7632963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.
    Arcellana-Panlilio MY; Egeler RM; Ujack E; Magliocco A; Stuart GC; Robbins SM; Coppes MJ
    Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
    Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
    Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.